NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - Representatives Chris Smith (R-NJ), Doris O. Matsui (D-CA), and Kweisi Mfume (D- MD) joined by Joanne Kurtzberg, MD, Professor of Pediatrics and Pathology at Duke University School of Medicine and Steven Devine, MD, Chief Medical Officer, NMDP SM on Capitol Hill on Sept. 10, 2025, in Washington, discuss the introduction of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 – a sustained bipartisan, public-private partnership to continually increase access to cell therapies for the thousands of patients annually with blood cancers and diseases who need a lifesaving transplant. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - Macy Howarth of Boston, a blood stem cell recipient, attends a briefing on Capitol Hill, where experts discussed the state of cell therapy research and lifesaving impact on patients on Sept. 10, 2025, in Washington. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - Steven Devine, MD, Chief Medical Officer, NMDP SM , at a Capitol Hill briefing, reflects on stories of the over 140,000 patients with blood cancers and diseases who have been positively impacted by innovative research in cell therapies on Sept. 10, 2025, in Washington. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - On Sept. 10, 2025, in Washington, NMDP SM team members help Congressional staff discover ways to get involved with the national registry and join the more than 42 million potential volunteer donors worldwide in selflessly donating lifesaving blood stem cells to patients in need. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - David Porter, MD, President of the American Society for Transplantation and Cellular Therapy ® , joined by Joanne Kurtzberg, MD, Professor of Pediatrics and Pathology at Duke University School of Medicine and Steven Devine, MD, Chief Medical Officer, NMDP SM at a Capitol Hill briefing to discuss innovation in cell therapy research and the lifesaving impact on patients on Sept. 10, 2025, in Washington. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - David Porter, MD, President of the American Society for Transplantation and Cellular Therapy ® , at the podium on Capitol Hill delivers remarks on innovation in cell therapy research and the lifesaving impact on patients on Sept. 10, 2025, in Washington. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - Macy Howarth of Boston, a blood stem cell recipient, attends a briefing on Capitol Hill, where experts discussed the state of cell therapy research and lifesaving impact on patients on Sept. 10, 2025, in Washington. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - Representatives Chris Smith (R-NJ), Doris O. Matsui (D-CA), and Kweisi Mfume (D- MD) joined by Joanne Kurtzberg, MD, Professor of Pediatrics and Pathology at Duke University School of Medicine and Steven Devine, MD, Chief Medical Officer, NMDP on Capitol Hill on Sept. 10, 2025, in Washington, discuss the introduction of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 – a sustained bipartisan, public-private partnership to continually increase access to cell therapies for the thousands of patients annually with blood cancers and diseases who need a lifesaving transplant. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - Steven Devine, MD, Chief Medical Officer, NMDP, at a Capitol Hill briefing, reflects on stories of the over 140,000 patients with blood cancers and diseases who have been positively impacted by innovative research in cell therapies on Sept. 10, 2025, in Washington. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - On Sept. 10, 2025, in Washington, NMDP team members help Congressional staff discover ways to get involved with the national registry and join the more than 42 million potential volunteer donors worldwide in selflessly donating lifesaving blood stem cells to patients in need. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - David Porter, MD, President of the American Society for Transplantation and Cellular Therapy ® , joined by Joanne Kurtzberg, MD, Professor of Pediatrics and Pathology at Duke University School of Medicine and Steven Devine, MD, Chief Medical Officer, NMDP at a Capitol Hill briefing to discuss innovation in cell therapy research and the lifesaving impact on patients on Sept. 10, 2025, in Washington. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
NMDP Applauds Congressional Champions for the Bipartisan Effort Introducing the Stem Cell Therapeutic and Research Reauthorization Act of 2025
IMAGE DISTRIBUTED FOR NMDP - David Porter, MD, President of the American Society for Transplantation and Cellular Therapy ® , at the podium on Capitol Hill delivers remarks on innovation in cell therapy research and the lifesaving impact on patients on Sept. 10, 2025, in Washington. (Joy Asico-Smith/AP Content Services for NMDP)
Абонирайте се
Влезте във Вашата БТА
Избиране на снимки
Моля потвърдете избраните снимки. Това действие не е свързано с плащане. Ако продължите, избраните снимки ще бъдат извадени от баланса на вашите активни абонаментни пакети.
Изтегляне на снимка
Моля потвърдете изтеглянето на снимката/ите
IMAGE DISTRIBUTED FOR NMDP - Representatives Chris Smith (R-NJ), Doris O. Matsui (D-CA), and Kweisi Mfume (D- MD) joined by Joanne Kurtzberg, MD, Professor of Pediatrics and Pathology at Duke University School of Medicine and Steven Devine, MD, Chief Medical Officer, NMDP SM on Capitol Hill on Sept. 10, 2025, in Washington, discuss the introduction of H.R. 5160, the Stem Cell Therapeutic and Research Reauthorization Act of 2025 – a sustained bipartisan, public-private partnership to continually increase access to cell therapies for the thousands of patients annually with blood cancers and diseases who need a lifesaving transplant. (Joy Asico-Smith/AP Content Services for NMDP)